FDA launches unified adverse event reporting dashboard

A new unified reporting and monitoring platform will process adverse-event reports ​submitted to the US Federal Drug Administration (FDA) for drugs, biologics, vaccines, cosmetics, ​and animal food on a single dashboard.

The ‌new platform is called the ⁠FDA Adverse Event Monitoring System (AEMS), and will contain real-time adverse-event reports ​for